These are the upcoming stock splits for the week of October 20 to October 24, based on TipRanks’ Stock Splits Calendar. A ...
The drug, called Rybelsus, is the only oral GLP-1 medication available. It was previously approved to treat Type 2 diabetes ...
More than 38 million Americans have diabetes and regular blood sugar monitoring is crucial. A team of researchers is working ...
A diabetes diet is a healthy eating plan that helps control your blood sugar. Here are the best foods to eat, no matter what type of diabetes you have.
Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...
Q3 2025 Management View Robert Ford, Chairman and CEO, reported organic sales growth of 7.5% excluding COVID test sales, highlighting double-digit growth in Medical Devices and high single-digit ...
As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors ...
Penn State researchers developed a non-invasive sensor for continuous monitoring of vitamin B6 and glucose levels in sweat, ...
Abbott (NYSE: ABT) shares dipped before hours today on third-quarter results that fell short of the consensus Wall Street ...
Between 2025 and 2035, the ingestible sensors market is expected to record over 72.4% growth, driven by increasing adoption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback